EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses

Tong Chen, Zhe Ding, Jiaming Lan, Gary Wong

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1174030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Tong Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Viral Hemorrhagic Fevers Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shan…. Hauptthemen laut MEDLINE: Rift Valley fever virus, Hemorrhagic Fever Virus, Crimean-Congo, Vaccines, Hemorrhagic Fever, Crimean. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased human activities around the globe and the rapid development of once rural regions have increased the probability of contact between humans and wild animals. A majority of bunyaviruses are of zoonotic origin, and outbreaks may result in the substantial loss of lives, economy contraction, and social instability. Many bunyaviruses require manipulation in the highest levels of biocontainment, such as Biosafety Level 4 (BSL-4) laboratories, and the scarcity of this resource has limited the development speed of vaccines for these pathogens. Meanwhile, new technologies have been created, and used to innovate vaccines, like the mRNA vaccine platform and bioinformatics-based antigen design. Here, we summarize current vaccine developments for three different bunyaviruses requiring work in the highest levels of biocontainment: Crimean-Congo Hemorrhagic Fever Virus (CCHFV), Rift Valley Fever Virus (RVFV), and Hantaan virus (HTNV), and provide perspectives and potential future directions that can be further explored to advance specific vaccines for humans and livestock.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rift Valley fever virusHemorrhagic Fever Virus, Crimean-CongoVaccinesHemorrhagic Fever, CrimeanAnimalsHumans

Stichwörter der Autor:innen

Crimean-Congo Hemorrhagic Fever VirusHantaan virusRift Valley Fever Virusbunyavirusesvaccines

Substanzen

Vaccines

Autor:innen und Institutionen

  • Viral Hemorrhagic Fevers Research Unit, Chinese Academy of Sciences (CAS) Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences (CAS), Shanghai, China.
  • University of Chinese Academy of Sciences, Beijing, China.

Zitieren

APA

Chen, T., Ding, Z., Lan, J., & Wong, G. (2023). Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1174030

Vancouver

Chen T, Ding Z, Lan J, Wong G. Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1174030

BibTeX
@article{Chen2023,
  author = {Chen, Tong and Ding, Zhe and Lan, Jiaming and Wong, Gary},
  title = {Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1174030}
}
Kostenlos starten →